![](http://www.alamy.com/thumbs/6/8C29C566-543C-4826-A0E0-91301110C8E3/2ADCP83.jpg)
Polarised light micrograph (PLM) of Cetuximab/Erbitx chemotherapy drug crystals. This drug, marketed as Erbitux, is used to treat metastatic head and
Polarised light micrograph (PLM) of Cetuximab/Erbitx chemotherapy drug crystals. This drug, marketed as Erbitux, is used to treat metastatic head and neck cancers spread from colorectal cancer. It is a monoclonal antibody that acts by inhibiting epidermal growth factor receptor (EGFR), therefore blocking the signals that tell the cancer cells to grow and divide. Horizontal object size of this image section: mm.
Size: 5472px × 3648px
Photo credit: © ALFRED PASIEKA/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: anthracycline, anti-cancer, breast, cancer, chemotherapy, condition, cytotoxic, disease, disorder, drug, epirubicin, gastric, healthcare, light, lm, lung, lymphoma, medical, medicine, micrograph, oncology, ovarian, pharmaceutical, pharmorubicin, plm, polarised, polarized, stomach, treat, treatment, tumor, tumour